Filing Flows › Idexx Laboratories (IDXX) › How it makes money
How Idexx Laboratories (IDXX) makes money
Idexx Laboratories (IDXX) made $1.2B of revenue in the third quarter 2026 (Q3 2026), +10% from a year earlier. Product revenue brought in $723M (60%); Service revenue brought in $491M (40%). Of every dollar of revenue, 63¢ was left as gross profit, 33¢ was left as operating profit, 26¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Product revenue | $723M | 59.5% | +0.6% | +10% |
| Service revenue | $491M | 40.5% | -1% | +9% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $1.2B | 100.0% |
| Cost of revenue | $450M | 37.1% |
| Gross profit | $764M | 62.9% |
| Operating expenses | $362M | 29.8% |
| Operating profit | $402M | 33.1% |
| Income tax | $82.2M | 6.8% |
| Net earnings | $317M | 26.1% |
| Operating cash flow | $450M | 37.0% |
| Free cash flow | $421M | 34.7% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $1.2B | +10% |
| Q2 2026 | $1.2B | +10% |
| Q1 2026 | $1.1B | +14% |
| Q4 2025 | $1.1B | +14% |
| Q3 2025 | $1.1B | +13% |
| Q2 2025 | $1.1B | +11% |
| Q1 2025 | $998M | +4% |
From Idexx Laboratories' 10-Q filed Nov 2, 2026 (on EDGAR).
Questions
How does Idexx Laboratories make money?
Idexx Laboratories (IDXX) made $1.2B of revenue in the third quarter 2026 (Q3 2026), +10% from a year earlier. Product revenue brought in $723M (60%); Service revenue brought in $491M (40%). Of every dollar of revenue, 63¢ was left as gross profit, 33¢ was left as operating profit, 26¢ was left as net earnings.
What is Idexx Laboratories' biggest business?
Product revenue: $723M in the third quarter 2026, 60% of revenue, +10% from a year earlier.
What is Idexx Laboratories' profit margin?
Net earnings were $317M, 26.1% of revenue, in the third quarter 2026; the operating margin was 33.1%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.